China: A new study, published in Diabetes, Metabolic Syndrome and Obesity, has shed light on the potential role of specific ...

A new study published in the journal of Diabetes Research and Clinical Practice showed that higher stroke risk is associated ...

Speaking at a public forum in Kuala Lumpur in 2023, a senior officer from Ministry of Health’s (MOH) planning division ...

Dietary supplements for diabetes are generally not recommended, but some research shows the benefits of using them to manage ...

Fecal microbiota analysis of pregnant women may provide early identification of those at risk for gestational diabetes.

Discover a study highlighting the high prevalence of MASLD and liver fibrosis in patients with type 2 diabetes using ...

Biocon Biologics receives USFDA approval for Kirsty, an interchangeable biosimilar to NovoLog, expanding their insulin ...

Apart from simple diagnosis, the study takes an important step toward predictive health monitoring by modeling the risk of ...

Biocon Biologics receives USFDA approval for Kirsty, an interchangeable biosimilar to NovoLog. This rapid-acting insulin ...

Biocon announced that its subsidiary, Biocon Biologics, has received US Food and Drug Administration (USFDA) approval for Kirsty (Insulin Aspart-xjhz) 100 units/ml, to improve glycemic control in ...

Aging men aren't just battling time—they're up against rising blood sugar. New research reveals that subtle increases in ...

Kirsty, Biocon's rapid-acting insulin, is the first FDA-approved interchangeable biosimilar to NovoLog in the US and will be ...